Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
Aehr Test Systems director Rhea J. Posedel reported open-market sales of company stock. On April 22, 2026, a trust associated with Posedel sold 604 shares of Aehr Test Systems common stock at $95.00 per share, reported as indirect ownership.
On the same date, Posedel directly sold an additional 17,115 shares at $100.00 per share. After these transactions, filings show 396,375 shares held indirectly by a trust and 45,261 shares held directly, with the indirect amount including shares subject to unvested restricted stock units. Overall, the activity reflects a partial reduction rather than an exit.
AEHR Test Systems executive Alistair N. Sporck, VP Contactor Business Unit, reported an indirect open‑market sale of 2,000 shares of common stock at $93.495 per share through a trust. After this transaction, the trust holds 5,177 shares indirectly. Sporck also reports 20,294 shares held directly, and this direct amount includes shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS EVP Alberto Salamone reported two open-market sales of common stock. He sold 15,000 shares at $94.56 on April 21, 2026 and 15,000 shares at $89.57 on April 20, 2026, totaling 30,000 shares sold.
After these sales, he directly holds 48,025 shares of AEHR common stock. A footnote states this amount includes shares subject to unvested restricted stock units, meaning part of his reported holdings are still vesting over time.
Aehr Test Systems director Howard T. Slayen reported a charitable stock gift. He transferred 1,800 shares of Common Stock as a bona fide gift at a stated price of $0.00 per share. The shares were donated to a Donor Advised Charitable Giving Fund.
After the gift, Slayen directly owns 176,528 shares of Aehr Test Systems common stock, and this amount includes shares subject to unvested restricted stock units. The filing shows no option exercises or open-market stock purchases or sales, only this charitable transfer.
AEHR insider Rhea Posedel reported multiple sales of common stock in April 2026 as disclosed on a Form 144. The filing lists individual trades including 30,000 shares on 04/09/2026 for $2,100,000 and other April trades with proceeds shown for each date. The filing also shows previously issued shares from compensation (604 shares, 10/20/2020) and an ESOP award (17,115 shares, 06/02/2025).
Alistair Sporck reported sales of Common Stock of Charles Schwab Corp. under a Rule 144 notice. The filing lists three transactions: 3,000 shares sold on 02/09/2026 for $82,716, 2,000 shares sold on 04/10/2026 for $134,730, and 2,000 shares sold on 04/16/2026 for $163,760.
The form also lists shares associated with an Employee Stock Purchase Plan dated 04/01/2024 (1,181 shares) and 10/01/2024 (819 shares) via payroll deductions.
Aehr Test Systems director Geoffrey Scott reported net open-market sales of 60,000 shares of Common Stock. Entities associated with him sold 50,000 shares at $95.00 per share through his spouse and 10,000 shares at $91.00 per share through a trust.
Following these transactions, he reports 52,864 shares held directly, 50,000 shares held indirectly by his spouse, and 50,686 shares held indirectly by a trust. The reported amounts include shares subject to unvested restricted stock units.
Aehr Test Systems executive Vernon Rogers sold 5,000 shares of Common Stock in an open-market transaction at $90.00 per share. After the sale, he directly holds 147,716 shares, which the disclosure states include shares subject to unvested restricted stock units. The transaction represents a small portion of his reported holdings and reflects a routine sale by the company’s Executive Vice President of Sales & Marketing.
Aehr Test Systems director Rhea J. Posedel reported an open-market sale of 8,787 shares of Common Stock at an average price of $96.0233 per share. The transaction occurred on April 21, 2026 and was recorded as a non-derivative sale.
Following the sale, she directly holds 62,376 Aehr shares. A separate indirect holding entry shows 396,979 shares held by a trust, and a footnote explains that this amount includes shares subject to unvested restricted stock units.
Aehr Test Systems executive vice president of sales and marketing Vernon Rogers reported an open-market sale of 6,486 shares of Common Stock at $94.0904 per share on April 21, 2026.
After this transaction, he directly holds 152,716 shares, and this figure includes shares underlying unvested restricted stock units. The sale amounts to roughly a small single-digit percentage of his reported holdings.